# A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

> **NCT06925100** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 180 (actual)

## Conditions studied

- Primary Hypercholesterolemia or Mixed Hyperlipidemia

## Interventions

- **DRUG:** Bempedoic acid 180 mg tablet

## Key facts

- **NCT ID:** NCT06925100
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-01
- **Primary completion:** 2025-10-15
- **Final completion:** 2025-10-15
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06925100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06925100, "A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06925100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*